 Proactive Investors USA & Canada |
GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results
FOXBusiness … Wednesday that their combined treatment for patients with chronic obstructive pulmonary disorder and asthma posted strong results in a clinical study. … Glaxo, Theravance report Relovair safety data GSK and Theravance announce combination ICS/LABA Phase II results in the … GlaxoSmithKline and Theravance announce positive phase II results for Relovair … |
View full post on asthma – Google News